Direct oral anticoagulants

Thomas G. DeLoughery

doi:10.1007/978-3-319-09312-3_24

Direct oral anticoagulants

Thomas G. DeLoughery

Knight Cancer Institute

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

This chapter reviews the new direct oral anticoagulants–thrombin inhibitor and Xa inhibitors. The specific drugs are reviewed as well as the specific indications–prevention and treatment of deep venous thrombosis, stroke prevention in atrial fibrillation, and then acute coronary syndrome. Finally, common issues such as monitoring and choosing the appropriate patient to use the drugs are reviewed.

Original language	English (US)
Title of host publication	Hemostasis and Thrombosis, Third Edition
Publisher	Springer International Publishing
Pages	121-124
Number of pages	4
ISBN (Electronic)	9783319093123
ISBN (Print)	9783319093116
DOIs	https://doi.org/10.1007/978-3-319-09312-3_24
State	Published - Jan 1 2015

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-3-319-09312-3_24

Cite this

@inbook{7bba7bbb877445f2a214c83edc328c4c,

title = "Direct oral anticoagulants",

abstract = "This chapter reviews the new direct oral anticoagulants–thrombin inhibitor and Xa inhibitors. The specific drugs are reviewed as well as the specific indications–prevention and treatment of deep venous thrombosis, stroke prevention in atrial fibrillation, and then acute coronary syndrome. Finally, common issues such as monitoring and choosing the appropriate patient to use the drugs are reviewed.",

author = "DeLoughery, {Thomas G.}",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing Switzerland 1999, 2004, 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-319-09312-3_24",

language = "English (US)",

isbn = "9783319093116",

pages = "121--124",

booktitle = "Hemostasis and Thrombosis, Third Edition",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Direct oral anticoagulants

AU - DeLoughery, Thomas G.

N1 - Publisher Copyright: © Springer International Publishing Switzerland 1999, 2004, 2015.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - This chapter reviews the new direct oral anticoagulants–thrombin inhibitor and Xa inhibitors. The specific drugs are reviewed as well as the specific indications–prevention and treatment of deep venous thrombosis, stroke prevention in atrial fibrillation, and then acute coronary syndrome. Finally, common issues such as monitoring and choosing the appropriate patient to use the drugs are reviewed.

AB - This chapter reviews the new direct oral anticoagulants–thrombin inhibitor and Xa inhibitors. The specific drugs are reviewed as well as the specific indications–prevention and treatment of deep venous thrombosis, stroke prevention in atrial fibrillation, and then acute coronary syndrome. Finally, common issues such as monitoring and choosing the appropriate patient to use the drugs are reviewed.

UR - http://www.scopus.com/inward/record.url?scp=84944544463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944544463&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-09312-3_24

DO - 10.1007/978-3-319-09312-3_24

M3 - Chapter

AN - SCOPUS:84944544463

SN - 9783319093116

SP - 121

EP - 124

BT - Hemostasis and Thrombosis, Third Edition

PB - Springer International Publishing

ER -

Direct oral anticoagulants

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this